Physician profile
Todd C Bennett
NPI 1548233562
$15,887.31
in general payments reported to CMS, 2019-2025
15 companies · $415 in 2025
The $415 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $92.97 · 2021: $227 · 2022: $206 · 2023: $112 · 2024: $128 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $435 · Travel and Lodging: $220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $435.34 |
| Travel and Lodging | $219.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $14,674.24 | 2019-2023 | Xarelto |
| Intuitive Surgical, INC. | $295.96 | 2025 | |
| Change Healthcare Technologies, LLC | $266.40 | 2021-2024 | Change Healthcare Cardiology |
| Merck Sharp & Dohme LLC | $154.98 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| Astrazeneca Pharmaceuticals Lp | $87.92 | 2019-2021 | |
| Pfizer INC. | $69.80 | 2023-2025 | |
| Novo Nordisk INC | $60.29 | 2025 | Rybelsus, Ozempic |
| Novartis Pharmaceuticals Corporation | $59.81 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $59.55 | 2019-2022 | |
| Chiesi USA, INC. | $54.51 | 2020-2021 | |
| Melinta Therapeutics, LLC | $35.31 | 2019-2020 | |
| Neurelis, INC. | $22.93 | 2023 | Valtoco |
| Amgen INC. | $18.72 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.49 | 2024 | Lifevest |
| Boston Scientific Corporation | $11.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.